FDA Approved: NARCAN — Supplemental Application (Emergent Devices Inc.)

View source ↗

Summary

FDA approved a supplemental application for Narcan nasal naloxone, submitted by Emergent Devices Inc., for the nasal naloxone product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• NARCAN (Naloxone hydrochloride nasal)

Snippet

SUPPL AP for NARCAN (NALOXONE HYDROCHLORIDE NASAL)